Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seock-Ah Im

Showing results (1-10 of 567) with videos related to

Pageof 57
Sort By:
Nature Reviews. Cancer|August 14, 2024
Tracing the evolutionary history of breast cancerJiwon Koh, Seock-Ah Im
Cancers|February 13, 2020
PARP Inhibitors as Therapeutics: Beyond Modulation of PARylationAhrum Min, Seock-Ah Im
Cancer Research and Treatment|December 19, 2025
Redefining HER2 in Breast Cancer: From Conventional Positivity to Low and Ultralow in the New Era of Antibody-Drug ConjugatesJiwon Koh, Seock-Ah Im
The New England Journal of Medicine|June 15, 2022
Trastuzumab Deruxtecan for Breast Cancer. ReplyJavier Cortés, Seock-Ah Im, Jillian Cathcart
Advances in Experimental Medicine and Biology|May 13, 2021
DNA Damage Repair Inhibitor for Breast Cancer TreatmentAhrum Min, Kyung-Hun Lee, Seock-Ah Im
The New England Journal of Medicine|October 17, 2019
Ribociclib and Endocrine Therapy in Breast Cancer. ReplySeock-Ah Im, Yen-Shen Lu, Debu Tripathy
Breast Cancer (Tokyo, Japan)|January 6, 2018
Subgroup analysis of patients with HER2-negative metastatic breast cancer in the second-line setting from a phase 3, open-label, randomized study of eribulin mesilate versus capecitabineXavier Pivot, Seock Ah Im, Matthew Guo, et al.
Cancer Informatics|October 21, 2021
Lymph Node Ratio after Neoadjuvant Chemotherapy for Stage II/III Breast Cancer: Prognostic Value Measured with Gini's Mean Difference of Restricted Mean Survival TimesBhumsuk Keam, Olena Gorobets, Vincent Vinh-Hung, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2011
Why, when, and how to prevent hepatitis B virus reactivation in cancer patients undergoing chemotherapyBhumsuk Keam, Jeong-Hoon Lee, Seock-Ah Im, et al.
Cancer Research and Treatment|October 11, 2023
Recent Developments in the Therapeutic Landscape of Advanced or Metastatic Hormone Receptor-Positive Breast CancerEunice Yoojin Lee, Dae-Won Lee, Kyung-Hun Lee, et al.
Pageof 57

Showing results (1-10 of 567) with videos related to

Sort By:
Pageof 57
Nature Reviews. Cancer|August 14, 2024
Tracing the evolutionary history of breast cancerJiwon Koh, Seock-Ah Im
Cancers|February 13, 2020
PARP Inhibitors as Therapeutics: Beyond Modulation of PARylationAhrum Min, Seock-Ah Im
Cancer Research and Treatment|December 19, 2025
Redefining HER2 in Breast Cancer: From Conventional Positivity to Low and Ultralow in the New Era of Antibody-Drug ConjugatesJiwon Koh, Seock-Ah Im
The New England Journal of Medicine|June 15, 2022
Trastuzumab Deruxtecan for Breast Cancer. ReplyJavier Cortés, Seock-Ah Im, Jillian Cathcart
Advances in Experimental Medicine and Biology|May 13, 2021
DNA Damage Repair Inhibitor for Breast Cancer TreatmentAhrum Min, Kyung-Hun Lee, Seock-Ah Im
The New England Journal of Medicine|October 17, 2019
Ribociclib and Endocrine Therapy in Breast Cancer. ReplySeock-Ah Im, Yen-Shen Lu, Debu Tripathy
Breast Cancer (Tokyo, Japan)|January 6, 2018
Subgroup analysis of patients with HER2-negative metastatic breast cancer in the second-line setting from a phase 3, open-label, randomized study of eribulin mesilate versus capecitabineXavier Pivot, Seock Ah Im, Matthew Guo, et al.
Cancer Informatics|October 21, 2021
Lymph Node Ratio after Neoadjuvant Chemotherapy for Stage II/III Breast Cancer: Prognostic Value Measured with Gini's Mean Difference of Restricted Mean Survival TimesBhumsuk Keam, Olena Gorobets, Vincent Vinh-Hung, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2011
Why, when, and how to prevent hepatitis B virus reactivation in cancer patients undergoing chemotherapyBhumsuk Keam, Jeong-Hoon Lee, Seock-Ah Im, et al.
Cancer Research and Treatment|October 11, 2023
Recent Developments in the Therapeutic Landscape of Advanced or Metastatic Hormone Receptor-Positive Breast CancerEunice Yoojin Lee, Dae-Won Lee, Kyung-Hun Lee, et al.
Pageof 57